Omega-3 Fatty Acids and FFAR4

Area of Science:

• Biochemistry
• Molecular Biology
• Metabolic Research

Background:

• Omega-3 fatty acids (ω3-FAs) are recognized for their beneficial effects on obesity, type 2 diabetes, and metabolic disorders.
• These effects are largely attributed to the anti-inflammatory properties mediated by the free fatty acid receptor 4 (FFAR4).

Purpose of the Study:

• To review the current understanding of the interaction between ω3-FAs and FFAR4.
• To explore the therapeutic potential of ω3-FAs and FFAR4 targets for metabolic diseases.

Main Methods:

• The review synthesizes existing research on ω3-FA binding to FFAR4.
• It examines the downstream signaling pathways, including receptor phosphorylation and β-arrestin-2 interaction.
• The study analyzes FFAR4's role in inflammation, glucose homeostasis, adiposity, and taste preference.

Main Results:

• ω3-FA stimulation of FFAR4 leads to receptor phosphorylation and subsequent interaction with β-arrestin-2.
• This interaction disrupts the inflammatory cascade by sequestering TAB1, thereby reducing inflammation.
• FFAR4 signaling is implicated in regulating glucose homeostasis, adiposity, gastrointestinal peptide secretion, and taste preference.

Conclusions:

• The ω3-FA-FFAR4 axis represents a significant pathway for mitigating inflammation and metabolic dysfunction.
• Targeting FFAR4 presents a promising strategy for developing novel therapeutics for metabolic diseases.
• Further research into this interaction could unlock new applications for ω3-FAs in health and disease management.